SPNE - シ―スパイン・ホ―ルディングス （SeaSpine Holdings Corporation） シ―スパイン・ホ―ルディングスSPNEのチャート
SPNEの企業情報
| symbol | SPNE |
|---|---|
| 会社名 | SeaSpine Holdings Corp （シ―スパイン・ホ―ルディングス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries including spine hip and extremities procedures. シ―スパイン・ホ―ルディングスは米国の医療テクノロジ―企業。脊髄障害治療のための外科的ソリュ―ションの開発・商業化に従事する。神経外科や脊髄外科の分野で、腰椎、胸椎、頸椎などの脊椎の融合・固定のための製品や技術を米国内外に提供する。本社はカリフォルニア州ビスタ。 SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide. |
| 本社所在地 | 5770 Armada Drive Carlsbad CA 92008 USA |
| 代表者氏名 | Keith C. Valentine キースC.バレンタイン |
| 代表者役職名 | President Chief Executive Officer |
| 電話番号 | +1 760-727-8399 |
| 設立年月日 | 42036 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 327人 |
| url | www.seaspine.com |
| nasdaq_url | https://www.nasdaq.com/symbol/spne |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -18.90500 |
| 終値（lastsale） | 17.8993 |
| 時価総額（marketcap） | 263889898.9797 |
| 時価総額 | 時価総額（百万ドル） 296.76210 |
| 売上高 | 売上高（百万ドル） 135.30800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 287.49910 |
| 当期純利益 | 当期純利益（百万ドル） -55.53500 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 SeaSpine Holdings Corp revenues increased 5% to $69.6M. Net loss decreased 16% to $14.5M. Revenues reflect United States segment increase of 5% to $62.2M International segment increase of 4% to $7.4M. Lower net loss reflects Research and development decrease of 13% to $5.6M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.46 to -$1.01. |
SPNEのテクニカル分析
SPNEのニュース
SeaSpine Holdings Corp (SPNE) Q3 2022 Earnings Call Transcript 2022/11/02 03:23:24 Seeking Alpha
SeaSpine Holdings Corp (NASDAQ:NASDAQ:SPNE) Q3 2022 Earnings Conference Call November 01, 2022, 16:30 ET Company Participants Greg Chodaczek - IR Keith Valentine - President, CEO &…
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of SeaSpine Holdings Corp. - SPNE 2022/11/02 02:15:00 PR Newswire
NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at…
SeaSpine GAAP EPS of -$0.42 misses by $0.12, revenue of $67.1M beats by $1.65M 2022/11/01 20:21:56 Seeking Alpha
SeaSpine press release (SPNE): Q3 GAAP EPS of -$0.42 misses by $0.12.Revenue of $67.1M (+44.5% Y/Y) beats by $1.65M.2022 Financial OutlookSeaSpine expects full-year 2022 revenue to…
Can you now get a good deal on SeaSpine Holdings Corporation’s shares? 2022/10/27 15:00:00 US Post News
SeaSpine Holdings Corporation (NASDAQ:SPNE) closed Wednesday at $6.21 per share, up from $5.86 a day earlier. While SeaSpine Holdings Corporation has overperformed by 5.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SPNE fell by -57.58%, with highs and lows ranging from $16.65 to $5.48, whereas […]
SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022 2022/10/24 11:00:00 GlobeNewswire
CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022. Members of the Company’s management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET.
"Outlook Moves Modestly Higher" Post Earning - Stifel Reiterates SeaSpine Holdings at Buy with $16 Price Target 2022/08/03 10:09:03 Investing.com
https://www.investing.com/news/pro/outlook-moves-modestly-higher-post-earning--stifel-reiterates-seaspine-holdings-at-buy-with-16-price-target-432SI-2861557
SeaSpine Holdings Corp (SPNE) CEO Keith Valentine on Q2 2022 Results - Earnings Call Transcript 2022/08/03 03:28:04 Seeking Alpha
SeaSpine Holdings Corp (NASDAQ:NASDAQ:SPNE) Q2 2022 Earnings Conference Call August 02, 2022, 16:30 ET Company Participants Leigh Salvo - Gilmartin Group Keith Valentine - President, CEO…
SeaSpine Holdings Corporation 2022 Q2 - Results - Earnings Call Presentation (NASDAQ:SPNE) 2022/08/03 03:02:10 Seeking Alpha
The following slide deck was published by SeaSpine Holdings Corporation in conjunction with their 2022 Q2 earnings call.
Recap: SeaSpine Holdings Q2 Earnings 2022/08/02 21:59:01 Benzinga
SeaSpine Holdings (NASDAQ: SPNE ) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings SeaSpine Holdings missed estimated earnings by 8.57%, reporting an EPS of $-0.38 versus an … Full story available on Benzinga.com
SeaSpine GAAP EPS of -$0.38 misses by $0.03, revenue of $56.3M beats by $1.97M, raises guidance 2022/08/02 20:35:01 Seeking Alpha
SeaSpine press release (SPNE): Q2 GAAP EPS of -$0.38 (vs
SeaSpine Announces Full Commercial Launch of WaveForm C 3D-printed Interbody System 2022/06/21 20:05:00 Wallstreet:Online
Company’s second fully commercialized interbody system featuring the novel WaveForm 3D printed technology and that addresses an estimated $200 million cervical market opportunity CARLSBAD, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today
SeaSpine announces full commercial launch of its WaveForm TO product for spinal procedures 2022/06/08 20:30:38 Seeking Alpha
SeaSpine (SPNE), a maker of surgical solutions for the treatment of spinal disorders, on Wednesday announced the full commercial launch of its 3D-printed WaveForm TO Interbody…
SeaSpine Announces Full Commercial Launch of the WaveForm TO (TLIF Oblique) 3D-Printed Interbody System 2022/06/08 20:05:00 Wallstreet:Online
Company’s first full commercial launch of novel 3D printed interbody product franchise that addresses estimated $500 million market opportunity CARLSBAD, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of
3 Med-Tech Stocks With Incredible Potential 2022/05/31 19:28:00 The Motley Fool
Here''s why our roundtable likes iRhythm, SeaSpine Holdings, and Owlet.
SeaSpine Holdings'' (SPNE) CEO Keith Valentine on Q1 2022 Results - Earnings Call Transcript 2022/05/04 01:51:09 Seeking Alpha
SeaSpine Holdings Corporation (NASDAQ:NASDAQ:SPNE) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Leigh Salvo – Investor Relations Keith Valentine – Chief…